Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2013 Sep 30;168(2):871-80.
doi: 10.1016/j.ijcard.2012.10.026. Epub 2012 Nov 17.

Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry

Affiliations
Multicenter Study

Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry

Marius M Hoeper et al. Int J Cardiol. .

Abstract

Background: Originally reported to occur predominantly in younger women, idiopathic pulmonary arterial hypertension (IPAH) is increasingly diagnosed in elderly patients. We aimed to describe the characteristics of such patients and their survival under clinical practice conditions.

Methods: Prospective registry in 28 centers in 6 European countries. Demographics, clinical characteristics, hemodynamics, treatment patterns and outcomes of younger (18-65 years) and elderly (>65 years) patients with newly diagnosed IPAH (incident cases only) were compared.

Results: A total of 587 patients were eligible for analysis. The median (interquartile, [IQR]) age at diagnosis was 71 (16) years. Younger patients (n=209; median age, 54 [16] years) showed a female-to-male ratio of 2.3:1 whereas the gender ratio in elderly patients (n=378; median age, 75 [8] years) was almost even (1.2:1). Combinations of PAH drugs were widely used in both populations, albeit less frequently in older patients. Elderly patients were less likely to reach current treatment targets (6 min walking distance>400 m, functional class I or II). The survival rates 1, 2, and 3 years after the diagnosis of IPAH were lower in elderly patients, even when adjusted for age- and gender-matched survival tables of the general population (p=0.006 by log-rank analysis).

Conclusions: In countries with an aging population, IPAH is now frequently diagnosed in elderly patients. Compared to younger patients, elderly patients present with a balanced gender ratio and different clinical features, respond less well to medical therapy and have a higher age-adjusted mortality. Further characterization of these patients is required.

Clinical trials registration: NCT01347216.

Keywords: Elderly; Hemodynamics; Hypertension; Pulmonary; Survival.

PubMed Disclaimer

Similar articles

Cited by

  • The Association Between Non-Clinically Apparent Liver Fibrosis and Pulmonary Arterial Hypertension in Hispanic Patients.
    Kalas MA, Khatab Y, Galura G, Alkhateeb H, Mukherjee D, Garcia H, Zuckerman M, Nickel NP. Kalas MA, et al. Cardiol Res. 2023 Dec;14(6):429-436. doi: 10.14740/cr1565. Epub 2023 Dec 9. Cardiol Res. 2023. PMID: 38187513 Free PMC article.
  • Differences in right ventricular function and response to targeted therapy between patients with IPAH and PAH-CHD.
    Zhu T, Wu P, Tan Z, Jin Q, Chen Y, Li L, Chen Z, Tang Y, Li J, Fang Z. Zhu T, et al. Front Pharmacol. 2023 Feb 13;14:1124746. doi: 10.3389/fphar.2023.1124746. eCollection 2023. Front Pharmacol. 2023. PMID: 36860300 Free PMC article.
  • Pulmonary Hypertension in Adults with Congenital Heart Disease: Real-World Data from the International COMPERA-CHD Registry.
    Kaemmerer H, Gorenflo M, Huscher D, Pittrow D, Apitz C, Baumgartner H, Berger F, Bruch L, Brunnemer E, Budts W, Claussen M, Coghlan G, Dähnert I, D'Alto M, Delcroix M, Distler O, Dittrich S, Dumitrescu D, Ewert R, Faehling M, Germund I, Ghofrani HA, Grohé C, Grossekreymborg K, Halank M, Hansmann G, Harzheim D, Nemes A, Havasi K, Held M, Hoeper MM, Hofbeck M, Hohenfrost-Schmidt W, Jurevičienė E, Gumbienè L, Kabitz HJ, Klose H, Köhler T, Konstantinides S, Köestenberger M, Kozlik-Feldmann R, Kramer HH, Kropf-Sanchen C, Lammers A, Lange T, Meyn P, Miera O, Milger-Kneidinger K, Neidenbach R, Neurohr C, Opitz C, Perings C, Remppis BA, Riemekasten G, Scelsi L, Scholtz W, Simkova I, Skowasch D, Skride A, Stähler G, Stiller B, Tsangaris I, Vizza CD, Vonk Noordegraaf A, Wilkens H, Wirtz H, Diller GP, Grünig E, Rosenkranz S. Kaemmerer H, et al. J Clin Med. 2020 May 13;9(5):1456. doi: 10.3390/jcm9051456. J Clin Med. 2020. PMID: 32414075 Free PMC article.
  • Epidemiology of pulmonary arterial hypertension.
    Jiang X, Jing ZC. Jiang X, et al. Curr Hypertens Rep. 2013 Dec;15(6):638-49. doi: 10.1007/s11906-013-0397-5. Curr Hypertens Rep. 2013. PMID: 24114080 Review.
  • Saudi guidelines on the diagnosis and treatment of pulmonary hypertension: 2014 updates.
    Idrees MM, Saleemi S, Azem MA, Aldammas S, Alhazmi M, Khan J, Gari A, Aldabbagh M, Sakkijha H, Aldalaan A, Alnajashi K, Alhabeeb W, Nizami I, Kouatli A, Chehab M, Tamimi O, Banjar H, Kashour T, Lopes A, Minai O, Hassoun P, Pasha Q, Mayer E, Butrous G, Bhagavathula S, Ghio S, Swiston J, Boueiz A, Tonelli A, Levy RD, Hoeper M, Levy RD. Idrees MM, et al. Ann Thorac Med. 2014 Jul;9(Suppl 1):S1-S15. doi: 10.4103/1817-1737.134006. Ann Thorac Med. 2014. PMID: 25076987 Free PMC article.

Publication types

Associated data